Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

COPD surgery risk: could a 10-Question test save lives?

NCT ID NCT07087626

Knowledge-focused Sponsor: Erzurum City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a short questionnaire called the COPD Assessment Test (CAT) can help predict breathing complications during and after surgery in people with COPD. Researchers will follow 120 patients aged 40-70 having elective surgery. They will compare those with low versus high CAT scores to see if higher scores mean more risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a simple tool to better plan anesthesia and care for COPD patients before surgery.
What could go wrong
This is an early observational study with only 120 people. The questionnaire may not reliably predict complications in all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients aged between 40 and 70 years with a diagnosis of stable-stage COPD according to GOLD criteria

Ages

40 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged between 40 and 70 years * Diagnosed with stable-stage Chronic Obstructive Pulmonary Disease (COPD) according to GOLD criteria * Scheduled for elective surgical intervention * Classified as ASA Physical Status II or III according to the American Society of Anesthesiologists (ASA) * Planned for postoperative follow-up and eligible for at least 72 hours of observation * Undergoing surgery with an expected duration of at least 150 minutes * Willing to participate voluntarily in the study Exclusion Criteria: * Patients younger than 40 years or older than 70 years * History of COPD exacerbation within the past 4 weeks * Presence of severe cardiac failure (EF \<30%), end-stage renal disease, or active malignancy * Neurological disorders or cognitive impairments * Requirement for invasive mechanical ventilation in the preoperative period * Altered consciousness or any condition preventing completion of forms before anesthesia * Undergoing surgery with an expected duration longer than 150 minutes * Unwillingness to participate in the study voluntarily

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic obstructive pulmonary disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD Preoperative risk assessment

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Erzurum City Hospital

    RECRUITING

    Erzurum, Yakutiye, 25240, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.